Articles About generic competition
April 17, 2014
Several generic drugmakers have banded together to ask the Supreme Court to allow them to market generic versions of Teva's Copaxone in the U.S.
April 04, 2014
Teva Pharmaceutical Industries -- the world’s largest manufacturer of generic drugs -- has criticized brand-name drug-makers for trying to block its generic versions.
March 03, 2014
Teva may find its new formula of Copaxone is a tough sell for insurers; the company is desperate to convert patients.
February 14, 2014
Pfizer's Australian unit is being sued by a federal regulator there for allegedly deterring competition of its generic version of the top-selling Lipitor.